allogeneic NK cells
1 abstract
Abstract
Clinical safety and efficacy observation of ex vivo-expanded peripheral blood-derived allogeneic NK cells in the treatment of refractory or recurrent ovarian cancer.Org: The First Affiliated Hospital of USTC, Anhui Provincial Hospital, Hefei, China, Division of Life Sciences and Medicine, University of Science and Technology of China, Institute of Immunology and the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Shanghai NK CellTech Co. Ltd,